chrX-108440110-C-T

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_033380.3(COL4A5):​c.-16C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000211 in 1,191,816 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 76 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00027 ( 0 hom., 5 hem., cov: 21)
Exomes 𝑓: 0.00021 ( 0 hom. 71 hem. )

Consequence

COL4A5
NM_033380.3 5_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.09

Publications

0 publications found
Variant links:
Genes affected
COL4A5 (HGNC:2207): (collagen type IV alpha 5 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Mutations in this gene are associated with X-linked Alport syndrome, also known as hereditary nephritis. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Aug 2010]
COL4A5 Gene-Disease associations (from GenCC):
  • Alport syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen, G2P
  • X-linked Alport syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Genomics England PanelApp, Myriad Women’s Health, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BS2
High Hemizygotes in GnomAd4 at 5 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A5NM_033380.3 linkc.-16C>T 5_prime_UTR_variant Exon 1 of 53 ENST00000328300.11 NP_203699.1 P29400-2Q49AM6A7MBN3
COL4A5NM_000495.5 linkc.-16C>T 5_prime_UTR_variant Exon 1 of 51 NP_000486.1 P29400-1Q49AM6A7MBN3
COL4A5XM_047441810.1 linkc.-392C>T 5_prime_UTR_variant Exon 1 of 54 XP_047297766.1
COL4A5XM_047441811.1 linkc.-16C>T 5_prime_UTR_variant Exon 1 of 42 XP_047297767.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A5ENST00000328300.11 linkc.-16C>T 5_prime_UTR_variant Exon 1 of 53 1 NM_033380.3 ENSP00000331902.7 P29400-2

Frequencies

GnomAD3 genomes
AF:
0.000274
AC:
30
AN:
109341
Hom.:
0
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00496
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000323
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000334
AC:
59
AN:
176879
AF XY:
0.000355
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00448
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000267
Gnomad OTH exome
AF:
0.00113
GnomAD4 exome
AF:
0.000205
AC:
222
AN:
1082475
Hom.:
0
Cov.:
28
AF XY:
0.000203
AC XY:
71
AN XY:
349805
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26103
American (AMR)
AF:
0.00
AC:
0
AN:
35055
Ashkenazi Jewish (ASJ)
AF:
0.00488
AC:
94
AN:
19270
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30126
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53289
European-Finnish (FIN)
AF:
0.0000498
AC:
2
AN:
40197
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4057
European-Non Finnish (NFE)
AF:
0.000133
AC:
110
AN:
828777
Other (OTH)
AF:
0.000351
AC:
16
AN:
45601
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
10
20
29
39
49
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000274
AC:
30
AN:
109341
Hom.:
0
Cov.:
21
AF XY:
0.000158
AC XY:
5
AN XY:
31623
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30005
American (AMR)
AF:
0.00
AC:
0
AN:
10192
Ashkenazi Jewish (ASJ)
AF:
0.00496
AC:
13
AN:
2622
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3463
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2439
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5660
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
237
European-Non Finnish (NFE)
AF:
0.000323
AC:
17
AN:
52585
Other (OTH)
AF:
0.00
AC:
0
AN:
1457
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000763
Hom.:
5
Bravo
AF:
0.000196

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 08, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.32
CADD
Benign
19
DANN
Benign
0.92
PhyloP100
1.1
PromoterAI
0.035
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs372416097; hg19: chrX-107683340; API